ArticleFrontiers in surgery2026
Use of axillary vascular grafts in prophylactic lymphovenous bypass: technical challenges and lessons learned.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer-related lymphedema (BCRL) is a common and debilitating complication of axillary lymph node dissection (ALND), affecting approximately 1 in 5 patients. While preventive lymphatic surgeries such as prophylactic lymphovenous bypass (pLVB) performed at the time of ALND have been shown to decrease the risk of developing BCRL, success is frequently limited by inadequate recipient veins within the axilla. In this study, we report our experience with utilizing axillary vascular grafts harvested from within the axillary dissection field to perform pLVB in vein-depleted axillae to prevent the development of BCRL in patients undergoing ALND. Methods: A retrospective review was performed of breast cancer patients undergoing ALND with planned pLVB at a single institution. Patients in whom axillary vascular grafts were used to enable lymphatic reconstruction were included. Demographic, oncologic, operative, and graft-specific variables were collected. Outcomes included successful lymphatic reconstruction and development of BCRL, assessed using a standardized institutional surveillance protocol incorporating circumferential measurements or perometry. Results: Thirty-two patients had a mean age of 52.3 years (SD, 12.9) and median BMI of 26.9 kg/m Conclusion: Axillary-based vascular grafting is a versatile strategy that expands reconstructive capacity during pLVB without additional donor-site morbidity. This approach enables completion of lymphatic reconstruction in anatomically challenging, vein-depleted axillae and represents a practical adjunct for immediate lymphatic reconstruction in high-risk breast cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.